Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 69

Results For "2023"

1090 News Found

Moderna announces regulatory submissions for its RSV vaccine
News | July 10, 2023

Moderna announces regulatory submissions for its RSV vaccine

The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia


Thermo Fisher Scientific to acquire CorEvitas for $912.5 million
News | July 10, 2023

Thermo Fisher Scientific to acquire CorEvitas for $912.5 million

Advances clinical research capabilities with leading regulatory grade registries platform


Cytel acquires French group stève consultants to expand real-world analytics capabilities
Digitisation | July 08, 2023

Cytel acquires French group stève consultants to expand real-world analytics capabilities

Cytel excels at using proven quantitative techniques to transform real-world data into actionable insights


Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course
News | July 08, 2023

Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course

This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries


Dabur India expects 10%+ consolidated growth in Q1 FY24
News | July 07, 2023

Dabur India expects 10%+ consolidated growth in Q1 FY24

However, PAT growth will be lower than operating profit growth mainly due to brand amortization expenditure on account of acquisition.


Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences
News | July 07, 2023

Aster DM Healthcare increases stake in Malabar Institute of Medical Sciences

Shareholding of the company in MIMS has increased from 76.01 per cent to 78.37 per cent


PrecisionLife Licenses University of Oxford data to discover personalised treatments for endometriosis patients
News | July 07, 2023

PrecisionLife Licenses University of Oxford data to discover personalised treatments for endometriosis patients

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments


Croda completes acquisition of Solus Biotech
News | July 06, 2023

Croda completes acquisition of Solus Biotech

This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments


Lupin receives tentative approval from USFDA for Dolutegravir Tablets for oral suspension
Drug Approval | July 05, 2023

Lupin receives tentative approval from USFDA for Dolutegravir Tablets for oral suspension

Dolutegravir Tablets for Oral Suspension (RLD Tivicay PD®) had estimated annual sales of USD 1 million in the U.S. (IQVIA MAT March 2023)


Syngene to acquire multi-modal facility from Stelis Biopharma
News | July 05, 2023

Syngene to acquire multi-modal facility from Stelis Biopharma

Adding 20,000 liters of installed biologics drug substance manufacturing capacity